We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RASP:RUSRaspadskaya Analysis

Data as of 2026-08-22 - not real-time

$0.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $0.000500, Actavia Life Sciences, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Relative strength is 0.0 — oversold — and the MACD signal is bullish.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 0.0%, a beta of 0.04 and a maximum drawdown of 87.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 0.0 signals oversold conditions
  • Trading below the 200-day average of 0.00

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 0.0 signals oversold conditions
  • Trading below the 200-day average of 0.00

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Thin trading liquidity raises execution risk
  • Maximum drawdown of 87.5%
  • Short-term moving averages stacked below long-term ones

Key Metrics & Analysis

Financial Health

P/B Ratio-0.2
Industry P/E31.1

Technical Analysis

TrendBearish
RSI0.0
Support$0.00
Resistance$0.00
MA 20$0.00
MA 50$0.00
MA 200$0.00
MACDBullish
VolumeStable
Fear & Greed Index94.41

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta0.04
0
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.